欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
CZ/H/1016/002
药品名称
Lafida
活性成分
tadalafil 20.0 mg
剂型
Film-coated tablet
上市许可持有人
SVUS Pharma a.s.
参考成员国 - 产品名称
Czechia (CZ)
互认成员国 - 产品名称
许可日期
2017/06/21
最近更新日期
2023/12/12
药物ATC编码
G04BE08 tadalafil
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Product Information
|
common_impack_20mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_5mg
Date of last change:2024/09/06
Final Product Information
|
common_outer_20mg_clean
Date of last change:2024/09/06
Final Product Information
|
common_outer_5mg_clean
Date of last change:2024/09/06
Final Product Information
|
common_pl_20mg_day210_corr_clean
Date of last change:2024/09/06
Final Product Information
|
common_pl_20mg_day210_corr_tracked
Date of last change:2024/09/06
Final Product Information
|
common_pl_5mg_day210_corr_clean
Date of last change:2024/09/06
Final Product Information
|
common_pl_5mg_day210_corr_tracked
Date of last change:2024/09/06
Final Product Information
|
common_spc_20mg_day210_corr_clean
Date of last change:2024/09/06
Final Product Information
|
common_spc_20mg_day210_corr_tracked
Date of last change:2024/09/06
Final Product Information
|
common_spc_5mg_day210_corr_clean
Date of last change:2024/09/06
Final Product Information
|
common_spc_5mg_day210_corr_tracked
Date of last change:2024/09/06
市场状态
Withdrawn（注：已撤市）
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase